Delivery Order SPE2DX22D0010-SPE2D825FFL78
Award Date 5/6/25
Potential Completion Date 5/7/25
Potential Value $31K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on March 18, 2025, for the supply of Vyvanse capsules 40mg, with a contract ceiling value of approximately $30K and an ultimate completion date of March 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Vyvanse capsules 60mg, with a ceiling value of $7,226.08 and a firm fixed price structure. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency's Medical Supply Chain awarded a $1,371.54 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for 100 tablets of Vyvanse 50mg. This is a firm fixed-price, competitively awarded contract with a completion date of September 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The delivery order represents a child contract under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,783.60 on May 13, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) by the Defense Logistics Agency. This contract utilizes firm fixed pricing under a non-set-aside, competitively awarded arrangement with an ultimate completion date of May 14, 2025. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,168.09 by the Defense Logistics Agency on April 24, 2025, for the supply of Vyvanse 40 mg capsules (100-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of April 25, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $12,936 firm fixed price delivery order for Vyvanse Caps 30mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside contract is funded by the Defense Logistics Agency's Medical Supply Chain and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Vyvanse 50 mg capsules (100-count units) with a ceiling value of $2,761.55 and an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $2,437.80 to AmerisourceBergen Drug Corp for the supply of Vyvanse 30 mg capsules (100 count) on August 7, 2025, with completion scheduled for August 8, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $16,827.85 for Vyvanse capsules 70mg on June 16, 2025, with completion expected by June 17, 2025. The contract utilizes firm fixed-price pricing and carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 29, 2025, by the Defense Logistics Agency to supply 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract is valued at $7,208.35 with firm fixed pricing and a completion date of July 30, 2025. This award represents a non-set-aside competitive award and serves as a child contract under...